FDA Import Refusal 1FX-3612602-7/10002/1 — Sanofi Vaccines Canada Ltd
The FDA refused shipment 1FX-3612602-7/10002/1 from Sanofi Vaccines Canada Ltd (Canada) on Jul 10, 2026. The refused product falls under Drugs and Biologics — INSULIN GLARGINE. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jul 10, 2026
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 58HCL09 INSULIN GLARGINE
- Charges
- 75